Fred Alger Management, LLC Neurocrine Biosciences Inc Transaction History

Fred Alger Management, LLC

$19.8 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$106.07 - $132.76 $8.76 Million - $11 Million	-82,599 Reduced 91.84%	7,339 $966,000
Q3 2023 Nov 14, 2023	BUY	$94.02 - $117.1 $8.46 Million - $10.5 Million	89,938 New	89,938 $10.1 Million
Q1 2023 May 15, 2023	SELL	$94.11 - $123.02 $19.4 Million - $25.4 Million	-206,521 Reduced 99.91%	176 $17,000
Q4 2022 Feb 14, 2023	BUY	$106.72 - $127.06 $22 Million - $26.2 Million	206,473 Added 92175.45%	206,697 $24.7 Million
Q2 2022 Aug 15, 2022	BUY	$75.79 - $100.07 $16,976 - $22,415	224 New	224 $22,000
Q2 2020 Aug 14, 2020	SELL	$85.09 - $130.36 $661,574 - $1.01 Million	-7,775 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$75.11 - $113.76 $2.29 Million - $3.48 Million	-30,550 Reduced 79.71%	7,775 $673,000
Q4 2019 Feb 14, 2020	BUY	$86.8 - $118.57 $869,996 - $1.19 Million	10,023 Added 35.41%	38,325 $4.12 Million
Q3 2019 Nov 14, 2019	BUY	$83.82 - $101.5 $352,714 - $427,112	4,208 Added 17.46%	28,302 $2.55 Million
Q2 2019 Aug 14, 2019	SELL	$72.24 - $91.27 $1.26 Million - $1.59 Million	-17,421 Reduced 41.96%	24,094 $2.03 Million
Q1 2019 May 14, 2019	SELL	$69.31 - $91.53 $299,627 - $395,684	-4,323 Reduced 9.43%	41,515 $3.66 Million
Q4 2018 Feb 14, 2019	SELL	$68.32 - $124.36 $986,950 - $1.8 Million	-14,446 Reduced 23.96%	45,838 $3.27 Million
Q3 2018 Nov 14, 2018	SELL	$98.88 - $125.85 $123,896 - $157,690	-1,253 Reduced 2.04%	60,284 $7.41 Million
Q2 2018 Jul 19, 2018	BUY	$75.3 - $105.99 $1.15 Million - $1.62 Million	15,315 Added 33.13%	61,537 $6.05 Million
Q1 2018 May 10, 2018	BUY	$75.88 - $92.43 $644,372 - $784,915	8,492 Added 22.51%	46,222 $3.83 Million
Q4 2017 Feb 14, 2018	BUY	$58.53 - $77.59 $1.87 Million - $2.48 Million	31,905 Added 547.73%	37,730 $2.93 Million
Q3 2017 Nov 14, 2017	BUY	$47.97 - $61.28 $279,425 - $356,956	5,825	5,825 $357,000

Others Institutions Holding NBIX

# of Institutions

625

Shares Held

94.2M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$1.78 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.26 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$647 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$323 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$234 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Account